logo
13:49 Jun 24

Parmax Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
73.61
+1.44 (+2.00%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Parmax Pharma Ltd. Financials

Parmax Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
73.61
+1.44 (+2.00%)
13:49 Jun 24
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

8/100
Expensive Valuation

Technical

80/100
Technically Bullish

Strength

9

Weakness

5

Opportunity

0

Threats

0

-8,146.36 %

ROE %

-14.82 %

ROA %

0.00

EPS

-13.81

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
18.25 15.42 11.05 28.2 12.11
Operating Expenses +
15.69 13.17 14.43 27.95 15.75
Raw Material
6.72 5.51 7.03 21.54 13.06
Increase Decrease in Cost
-0.01 -0.02 0.02 0 -3.18
Other Manufacturing Expense
3.82 3.34 3.14 2.2 0
Employee Cost
3.46 2.8 2.91 2.99 2.5
Miscellaneous Expenses
1.7 1.54 1.33 1.22 3.37
Operating Profit
2.56 2.25 -3.38 0.25 -3.64
Other Income
0.06 0.04 0.05 0.04 0.05
Depreciation
1.93 1.88 1.71 1.03 1.01
Interest
0.39 0.37 0.62 0.59 1.24
Profit before tax and exceptio..
0.3 0.05 -5.66 -1.32 -5.85
Exceptional Items
0 0 0 -1.07 0
PBT
0.3 0.05 -5.66 -2.4 -5.85
Provision for Taxation
0.16 0.15 0.12 -0.3 -1.69
Net Profit
0.14 -0.1 -5.78 -2.09 -4.16
NET Profit after MI
0 0 0 0 0
EPS
0.38 -0.28 -11.33 -5.6 -11.12
Operating Profit Margin (%)
14.03 14.59 -30.59 0.89 -30.06
Net Profit Margin (%)
0.77 -0.65 -52.31 -7.41 -34.35

Parmax Pharma Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 30.80 30.80 30.80 30.80 30.80 30.80
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 69.20 69.20 69.20 69.20 69.20 69.20
Shareholder Shares Holding %
Research 360 logo
Download Our App On: